Stainless steel bioreactor system in a fermentation lab

E. coli Fermentation Process Development & Non-GMP Protein Production

Book a meeting

As an experienced microbial fermentation CRO, VALIDOGEN offers advanced E. coli fermentation process development and non-GMP protein production services for efficient, scalable recombinant protein manufacturing. Building on more than a decade of expertise, including a long-standing technology and R&D collaboration with Boehringer Ingelheim, we support customers from early-stage protein expression to robust and cost-effective production processes. In addition to non-GMP recombinant protein production, and the rapid generation of E. coli protein samples using your existing expression strains, we also develop optimized fermentation and purification processes. This enables reliable scale-up and establishes a strong foundation for future manufacturing and pre-clinical development. 

E. coli Process Development at VALIDOGEN – Scope of Services

VALIDOGEN offers two complementary E. coli-based service pathways to support your recombinant protein development and manufacturing goals: non-GMP protein production using your existing expression strain, and comprehensive fermentation process development.

Non-GMP Protein Production
  • Seed culture experiments
  • Lab-scale production of recombinant protein samples in 1 L and 10 L bioreactors
  • Rapid generation of recombinant protein material
  • Standard downstream purification workflows
  • Delivery of protein samples
     
Fermentation process development
  • Targeted process optimization to maximize productivity
  • Process characterization aligned with QbD principles
  • Robustness testing to ensure stable performance across parameter ranges
  • Reproducibility verification through independent cultivation runs
  • Transfer-ready process design and documentation for efficient scale-up

Why choose VALIDOGEN for E.coli fermentation and process development

 

  • Shorter development timelines through efficient E. coli fermentation process development. Supported by proven protocols, industrial workflows, and parallel bioreactor systems that enable rapid evaluation of multiple process conditions.
  • Systematic process optimization through Design of Experiments (DoE), resulting in data-driven decisions, fewer development iterations, and faster identification of optimal operating conditions.
  • Higher confidence in scale-up success through robust process characterization and a thorough understanding of critical process parameters (CPPs).
  • Reproducible processes ready for technology transfer to pilot-scale facilities and industrial CMOs, reducing implementation risks during scale-up.
  • Improved manufacturing readiness through scalable fed-batch fermentation processes designed for consistent product quality, yield, and productivity.
    Access to industry-proven process know-how built on more than a decade of joint technology and R&D collaboration with Boehringer Ingelheim.
     

Our Services: From Protein Samples to Scale-up 


Integrated E. coli Fermentation Process Development and Protein Production Services: Our E. coli service portfolio includes non-GMP protein production and comprehensive fermentation process development to support recombinant protein projects from early evaluation through process scale-up. Using your existing expression strain, we generate E. coli protein samples and develop robust, scalable processes suitable for technology transfer and future manufacturing. 
 

Production of Protein Samples (Non-GMP)

As part of our E. coli protein expression service, VALIDOGEN offers non-GMP protein production using your existing E. coli expression strain, enabling rapid access to protein samples for analytical testing, characterization, and early-stage project evaluation. Based on our proven fermentation protocols, protein samples are produced in 1 L and 10 L bioreactor systems without the need for prior fermentation process development. Standard downstream purification workflows can be included to provide purified recombinant protein for functional studies and further characterization.
 

Fermentation scientists in a VALIDOGEN laboratory operating bioreactor systems for protein expression research..
Scientist using microbioreactor technology in Pichia strain development.

Fermentation Process Development and Optimization

VALIDOGEN develops and optimizes E. coli fermentation processes tailored to the requirements of your recombinant protein and production strain. Depending on project goals, our fermentation process development approach combines scientific expertise with established methodologies, including systematic testing of process parameters through Design of Experiments (DoE), to identify optimal operating conditions. Key cultivation parameters such as fed-batch feeding strategies, induction conditions, and temperature are optimized to improve productivity, yield, and product quality. Projects can range from targeted E. coli fermentation optimization to comprehensive process development programs that establish robust and scalable manufacturing processes. 

Process Characterization 

A thorough understanding of process performance is essential for robust and reproducible recombinant protein production. Through process characterization studies, VALIDOGEN generates the data required to identify Critical Process Parameters (CPPs), process variables that can directly impact product quality, yield, or process consistency. Following Quality by Design (QbD) principles, a systematic development approach that builds process understanding based on scientific data, we establish a strong knowledge base for process control and scale-up. This documentation is particularly valuable for customers planning to qualify their process for clinical development and future regulatory submissions.
 

VALIDOGEN fermentation specialists working in a fermentation laboratory at VALIDOGEN.

Process Robustness

Reliable manufacturing requires processes that perform consistently across different bioreactor systems and production scales. Through confirmation runs and performance verification studies, VALIDOGEN evaluates process robustness and demonstrates reproducible fermentation performance under defined operating conditions. This ensures that optimized E. coli fermentation processes deliver consistent product quality, yield, and productivity, providing a reliable foundation for scale-up, technology transfer, and future manufacturing activities. 
 

Technology Transfer and Scale-up Support 
 

VALIDOGEN supports a structured scale-up pathway from lab to pilot to industrial scale, enabling a smooth transition from E. coli fermentation process development to larger manufacturing environments. Based on robust process documentation and defined operating parameters, we facilitate efficient technology transfer and support collaboration with qualified CMO partners for subsequent GMP production. 

 

Downstream Process Development

To establish an efficient end-to-end manufacturing process, VALIDOGEN integrates upstream development with tailored downstream process development. Depending on product requirements, purification workflows may include chromatographic separation techniques such as affinity, ion-exchange, and size-exclusion chromatography. Process development activities focus on maximizing product recovery, improving yield, and achieving effective impurity clearance, including the removal of host cell proteins, nucleic acids, and other process-related contaminants. 

 

E. coli Fermentation Process Development and Protein Production Services

Key features
  • Development of fed-batch fermentation processes
  • Optimization of feeding strategies
  • Optimization of induction conditions
  • Control of key process parameters affecting productivity and protein quality
  • Confirmation of process robustness and reproducibility
  • Tech transfer & scale-up support

 

Technology & Deliverables

TECHNOLOGY

  • Cultivation in 1 L or 10 L bioreactors
  • Design of Experiment tools for efficient parameter scouting

DELIVERABLES

  • Non-GMP protein samples
  • Robust and optimized processes and cultivation protocols
  • Support for process transfer to desired facility

E.coli Downstream Process Development

Key features
  • Cell harvest, cell disruption and protein extraction
  • Development of chromatographic purification steps
  • Optimization of purification yields and product quality
     

 

Technology & Deliverables

TECHNOLOGY

  • Highly versatile equipment to perform systematic small-scale process development, as well as small to medium-scale production
  • Proven strategies for rapid process set-up
  • Established analytical tools for the target protein and process-related impurities (including host cell proteins and host cell DNA)

DELIVERABLES

  • Purified protein samples (small-scale, non-GMP production)
  • Scalable purification process
  • Full documentation to support process transfer

 

Frequently Asked Questions about E. coli Fermentation and Process Development

Does VALIDOGEN offer E. coli expression strain generation?

VALIDOGEN's E. coli fermentation process development services are designed for clients with established E. coli expression systems seeking expert support in process optimization, scale-up, and technology transfer. Expression strain generation can be performed upon request using commercially available E. coli strains selected by the customer. This enables VALIDOGEN to support projects where an E. coli expression construct is already available and the next step is to establish a suitable production strain for subsequent fermentation and purification process development.
For projects requiring strain engineering or alternative expression hosts, our proprietary UNLOCK PICHIA® platform enables the development of high-performance Pichia pastoris production strains with exceptional productivity. 
 

What is the typical timeline for a fermentation process development project at VALIDOGEN?

Project timelines depend on the scope and complexity of the development program required. Our suite of parallel bioreactor systems enables rapid testing of multiple conditions, allowing efficient optimization and accelerated process development. 

Up to which scale does VALIDOGEN develop processes? Is VALIDOGEN a GMP facility?

VALIDOGEN develops fermentation and purification processes at scales up to 10 L. While VALIDOGEN is not a GMP manufacturing facility, we deliver robust processes that can be efficiently implemented under GMP conditions at your selected CDMO or manufacturing partner.

Besides E. coli process development, does VALIDOGEN also support the production of protein samples?

Yes. In addition to fermentation process development, VALIDOGEN offers non-GMP protein production using your existing E. coli expression strain. We enable the rapid generation of protein samples in 1 L and 10 L bioreactor systems, providing sufficient material for early-stage evaluation, analytical testing, and functional studies. If required, proteins can be purified using established standard purification techniques. 

What types of recombinant proteins can VALIDOGEN develop E. coli processes for?

With more than 15 years of experience in microbial protein production, VALIDOGEN provides process development expertise for a wide range of proteins across different industries including growth factors, enzymes and antibody fragments.

What is the difference between VALIDOGEN's E. coli and Pichia service?

VALIDOGEN's core expertise is in strain and process optimization for recombinant protein expression in Pichia pastoris, supported by more than 15 years of experience in strain engineering, fermentation process development, and scale-up. Leveraging extensive microbial process know-how and a long-standing technology and R&D collaboration with Boehringer Ingelheim, VALIDOGEN also offers E. coli fermentation process development and non-GMP protein production. These services support customers with existing E. coli expression strains who require protein samples, process optimization, scale-up, or technology transfer support.

Want to work with Pichia pastoris? Explore our UNLOCK PICHIA® services.

VALIDOGEN's core expertise is the proprietary UNLOCK PICHIA® expression platform. Our service portfolio includes Feasibility Studies, Strain Development, and Fermentation Process Development, supporting recombinant protein projects from initial expression assessment through scale-up and technology transfer.

Let's talk - Get in touch

Iskandar Dib, PhD
Principal Scientist & Business Development Manager
Rosie Maddock, PhD
Business Development Manager

Have questions about E. coli process development? Our scientists are happy to discuss your project requirements. Send any project related requests to project@validogen.com, book a meeting, or use our contact form.

Get in touch